India's Morepen Laboratories soars on launching new diabetes drug
** Morepen Laboratories MORL.NS rises 7.4% to 46 rupees; set for biggest one-day pct gain in over six months ** Pharma co launches diabetes drug Empamore priced about ~90% below existing brands ** Stock set to snap five-day losing run ** More than 5.9 mln shares traded, over 1.5x the 30-day avg ** MORL loses 40% YTD (Reporting by Aleef Jahan in Bengaluru) ((aleefjahan.cs@thomsonreuters.com))
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall